Does cannabis interact with Levetiracetam?

**Disclaimer: This information is for educational purposes only and should not replace professional medical advice. Always consult healthcare providers before combining cannabis with prescription medications.** Cannabis can potentially interact with levetiracetam (Keppra), an anti-epileptic drug commonly prescribed for seizure disorders. The interaction primarily involves the cytochrome P450 enzyme system, though levetiracetam is unique among seizure medications as it's minimally metabolized by these liver enzymes. THC and CBD, cannabis's primary cannabinoids, can affect drug metabolism differently. CBD is a moderate inhibitor of CYP2C19 and CYP3A4 enzymes, while THC has weaker effects on these pathways. Since levetiracetam is largely eliminated unchanged through the kidneys (66% unchanged), the metabolic interaction risk is lower compared to other anti-epileptic drugs like carbamazepine or phenytoin. However, pharmacodynamic interactions remain a concern. Both cannabis and levetiracetam affect the central nervous system, potentially leading to additive sedative effects including drowsiness, dizziness, and cognitive impairment. Some patients report increased fatigue when combining these substances. Interestingly, emerging research suggests CBD may have anti-seizure properties. Clinical studies of CBD-based medications like Epidiolex have shown efficacy in certain epilepsy types. Some patients use medical cannabis alongside traditional anti-epileptic drugs, but this requires careful medical supervision. Monitoring considerations include watching for increased side effects like excessive sedation, mood changes, or coordination problems. Blood levels of levetiracetam are less likely to be affected compared to other seizure medications, but individual responses vary. Patients should never adjust seizure medications independently, as this can trigger breakthrough seizures or status epilepticus, a life-threatening condition. Any cannabis use should be disclosed to prescribing physicians, who can adjust dosing or monitoring protocols accordingly. The timing of administration may also matter - spacing doses several hours apart might minimize interaction potential.